Value chain stagesFinished Product

Products 121 to 130 of 171

Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/28 14:53 (6 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
PRGN-3005: Cancer by Intrexon
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:31 (5 years ago)
Date last modified: 2019/09/12 14:31 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: XON (NASDAQ)
Value chain stage: Finished Product
Biotech components: Gene Editing + Molecule
Business models: B2B
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 14:32 (5 years ago)
Date last modified: 2019/09/12 14:32 (5 years ago)
Known funding amount: N/A
Funding types: Shareholder Investment
Industry: Medical
Market status: Under Development
Organization type(s): Public Company
Product categories: Medical Treatment
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Biotech components: Enzyme
Business models: B2B + B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2020/12/18 14:35 (3 years ago)
Date last modified: 2020/12/18 14:35 (3 years ago)
Known funding amount: 5,000,000 EUR
Funding types: Venture Capital
Industry: Energy
Market status: Under Development
Organization type(s): Private Company
Product categories: Food
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Pyrolase Cellulase by BASF + Verenium
Biotech components: Enzyme
Business models: B2B
Country of production: Switzerland
Country of distribution: USA + Canada + Mexico
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2019/02/13 15:37 (5 years ago)
Known funding amount: 2,147,483,647 USD
Funding types: Shareholder Investment
Industry: Industrial
Market status: On the market
Organization type(s): Public Company
Product categories: Chemical
Production process: Open Release
Source: SynBio Database
Trading symbol: BASF SE (XETRA)
Value chain stage: Finished Product
Biotech components: Plant
Business models: B2C
Country of production: USA
Country of distribution: USA + Canada
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/09/28 14:35 (6 years ago)
Known funding amount: 70,000,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Rose Oil From Yeast by Ginkgo Bioworks
Biotech components: Microbe + Yeast
Business models: B2C
Country of production: USA
Country of distribution: USA
Intended consumer: Consumer
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/11/28 16:10 (5 years ago)
Known funding amount: 9,000,000 USD
Funding types: Private Funding
Industry: Novelty
Market status: Under Development
Organization type(s): Private Company
Product categories: Other
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Salk Ideal Plants by Salk Institute for Biological Studies
Biotech components: Gene Editing + Plant
Business models: B2C
Country of production: N/A
Country of distribution: N/A
Intended consumer: N/A
Date added: 2019/09/12 15:08 (5 years ago)
Date last modified: 2019/09/12 15:08 (5 years ago)
Known funding amount: N/A
Funding types: Public Funding
Industry: Ecosystem Restoration + Food & Agriculture
Market status: Early Stage Concept
Organization type(s): Private Company
Product categories: Plant
Production process: N/A
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Salt Tolerant Carrots by Salt Farm Texel
Biotech components: Plant
Business models: B2B
Country of production: Netherlands
Country of distribution: Netherlands + Pakistan + Bangladesh + Ghana
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:52 (6 years ago)
Known funding amount: 500,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product
Salt Tolerant Potatoes by Salt Farm Texel
Biotech components: Plant
Business models: B2B
Country of production: Netherlands
Country of distribution: Netherlands + Pakistan + Bangladesh + Ghana
Intended consumer: Commercial
Date added: 2018/08/30 11:49 (6 years ago)
Date last modified: 2018/10/08 14:53 (6 years ago)
Known funding amount: 500,000 USD
Funding types: Private Funding
Industry: Food & Agriculture
Market status: Under Development
Organization type(s): Private Company
Product categories: Plant
Production process: Open Release
Source: Web search
Trading symbol: N/A
Value chain stage: Finished Product